SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001021408-03-008078
Filing Date
2003-05-20
Accepted
2003-05-20 17:09:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 14D-9 dsc14d9a.htm SC 14D9/A 16131
3 LETTER TO THE COMPANY'S STOCKHOLDERS dex13.htm EX-13 5306
4 PRESS RELEASE dex14.htm EX-14 8949
  Complete submission text file 0001021408-03-008078.txt   32884
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filed by) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Subject) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-53269 | Film No.: 03713171
SIC: 2834 Pharmaceutical Preparations